Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury

被引:18
作者
Hayashi, K
Banno, H
Kadomatsu, K
Takei, Y
Komori, K
Muramatsu, T
机构
[1] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Vasc Surg, Nagoya, Aichi, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2005年 / 288卷 / 05期
关键词
molecular target; phosphorothioate; vascular restenosis;
D O I
10.1152/ajpheart.00555.2004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Restenosis is the major clinical problem of angioplasty. We have previously shown that neointima formation is strikingly suppressed in midkine (MK)- deficient mice. Neointima formation is restored if MK protein is administrated to the deficient mice. MK is a heparin- binding growth factor and implicated in the migration of inflammatory cells and vascular smooth muscle cells. Consistently, the suppression of neointima formation in the deficient mice is accompanied by suppression of recruitment of inflammatory cells into the vascular wall. Here, we evaluated the potential of MK antisense oligodeoxyribonucleotide (ODN) for the prevention of restenosis. We cloned the cDNA of rabbit MK, which showed a strongly conserved sequence in mammals. The balloon injury induced MK expression, with the maximum level occurring 7 - 14 days after angioplasty, in the rabbit carotid artery. Two antisense ODNs suppressed the production of MK in a rabbit kidney cell line, RK13 cells, one of which was then transfected into the arterial wall by means of lipofection immediately after balloon treatment. The antisense ODN suppressed MK induction in vivo and consequently suppressed neointima formation to 60% of the control level. These results suggest that MK is a candidate molecular target for the therapy for vascular restenosis.
引用
收藏
页码:H2203 / H2209
页数:7
相关论文
共 48 条
[1]  
*AM HEART ASS, 2001, 2002 HEART STROK STA
[2]   PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine [J].
Banai, S ;
Wolf, Y ;
Golomb, G ;
Pearle, A ;
Waltenberger, J ;
Fishbein, I ;
Schneider, A ;
Gazit, A ;
Perez, L ;
Huber, R ;
Lazarovichi, G ;
Rabinovich, L ;
Levitzki, A ;
Gertz, SD .
CIRCULATION, 1998, 97 (19) :1960-1969
[3]  
BAUTERS C, 1998, TXB CARDIOVASCULAR M, P2465
[4]   In-stent stenosis: pathology and implications for the development of drug eluting stents [J].
Bennett, MR .
HEART, 2003, 89 (02) :218-224
[5]   LRP: Role in vascular wall integrity and protection from atherosclerosis [J].
Boucher, P ;
Gotthardt, M ;
Li, WP ;
Anderson, RGW ;
Herz, J .
SCIENCE, 2003, 300 (5617) :329-332
[6]   THE ANTIPROLIFERATIVE ACTIVITY OF C-MYB AND C-MYC ANTISENSE OLIGONUCLEOTIDES IN SMOOTH-MUSCLE CELLS IS CAUSED BY A NONANTISENSE MECHANISM [J].
BURGESS, TL ;
FISHER, EF ;
ROSS, SL ;
BREADY, JV ;
QIAN, YX ;
BAYEWITCH, LA ;
COHEN, AM ;
HERRERA, CJ ;
HU, SSF ;
KRAMER, TB ;
LOTT, FD ;
MARTIN, FH ;
PIERCE, GF ;
SIMONET, L ;
FARRELL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :4051-4055
[7]  
DEUEL TF, 2000, ARCH BIOCHEM BIOPHYS, V397, P62
[8]   Drug-eluting stents in vascular intervention [J].
Fattori, R ;
Piva, T .
LANCET, 2003, 361 (9353) :247-249
[9]   INHIBITION OF NEOINTIMAL SMOOTH-MUSCLE ACCUMULATION AFTER ANGIOPLASTY BY AN ANTIBODY TO PDGF [J].
FERNS, GAA ;
RAINES, EW ;
SPRUGEL, KH ;
MOTANI, AS ;
REIDY, MA ;
ROSS, R .
SCIENCE, 1991, 253 (5024) :1129-1132
[10]   The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty [J].
Gunn, J ;
Holt, CM ;
Francis, SE ;
Shepherd, L ;
Grohmann, M ;
Newman, CMH ;
Crossman, DC ;
Cumberland, DC .
CIRCULATION RESEARCH, 1997, 80 (04) :520-531